BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

886 related articles for article (PubMed ID: 21520094)

  • 21. Percutaneous radiofrequency ablation therapy for patients with hepatocellular carcinoma during occlusion of hepatic blood flow. Comparison with standard percutaneous radiofrequency ablation therapy.
    Yamasaki T; Kurokawa F; Shirahashi H; Kusano N; Hironaka K; Okita K
    Cancer; 2002 Dec; 95(11):2353-60. PubMed ID: 12436442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiofrequency ablation versus percutaneous microwave coagulation therapy for small hepatocellular carcinomas: a retrospective comparative study.
    Ohmoto K; Yoshioka N; Tomiyama Y; Shibata N; Kawase T; Yoshida K; Kuboki M; Yamamoto S
    Hepatogastroenterology; 2007 Jun; 54(76):985-9. PubMed ID: 17629022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma.
    Harrison LE; Koneru B; Baramipour P; Fisher A; Barone A; Wilson D; Dela Torre A; Cho KC; Contractor D; Korogodsky M
    J Am Coll Surg; 2003 Nov; 197(5):759-64. PubMed ID: 14585410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy.
    Takahashi S; Kudo M; Chung H; Inoue T; Ishikawa E; Kitai S; Tatsumi C; Ueda T; Minami Y; Ueshima K; Haji S
    Oncology; 2007; 72 Suppl 1():98-103. PubMed ID: 18087189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Higher Efficiency of Percutaneous Microwave (MWA) Than Radiofrequency Ablation (RFA) in Achieving Complete Response in Cirrhotic Patients with Early Hepatocellular Carcinoma.
    Gaia S; Ciruolo M; Ribaldone DG; Rolle E; Migliore E; Mosso E; Vola S; Risso A; Fagoonee S; Saracco GM; Carucci P
    Curr Oncol; 2021 Feb; 28(2):1034-1044. PubMed ID: 33669107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radio-frequency ablation in cirrhotic patients with hepatocellular carcinoma.
    Arch-Ferrer JE; Smith JK; Bynon S; Eckhoff DE; Sellers MT; Bland KI; Heslin MJ
    Am Surg; 2003 Dec; 69(12):1067-71. PubMed ID: 14700292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiofrequency ablation as first-line treatment for small solitary hepatocellular carcinoma: long-term results.
    Peng ZW; Zhang YJ; Chen MS; Lin XJ; Liang HH; Shi M
    Eur J Surg Oncol; 2010 Nov; 36(11):1054-60. PubMed ID: 20846819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histologic evaluation and treatment outcome after sequential radiofrequency ablation and hepatic resection for primary and metastatic tumors.
    Hoffman AL; Wu SS; Obaid AK; French SW; Lois J; McMonigle M; Ramos HC; Sher LS; Lopez RR
    Am Surg; 2002 Dec; 68(12):1038-43. PubMed ID: 12516804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of seven staging systems in cirrhotic patients with hepatocellular carcinoma in a cohort of patients who underwent radiofrequency ablation with complete response.
    Guglielmi A; Ruzzenente A; Pachera S; Valdegamberi A; Sandri M; D'Onofrio M; Iacono C
    Am J Gastroenterol; 2008 Mar; 103(3):597-604. PubMed ID: 17970836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases.
    Tateishi R; Shiina S; Teratani T; Obi S; Sato S; Koike Y; Fujishima T; Yoshida H; Kawabe T; Omata M
    Cancer; 2005 Mar; 103(6):1201-9. PubMed ID: 15690326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up.
    Waki K; Aikata H; Katamura Y; Kawaoka T; Takaki S; Hiramatsu A; Takahashi S; Toyota N; Ito K; Chayama K
    J Gastroenterol Hepatol; 2010 Mar; 25(3):597-604. PubMed ID: 20074153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiofrequency ablation of hepatocellular carcinoma in patients with decompensated cirrhosis: evaluation of therapeutic efficacy and safety.
    Kim YK; Kim CS; Chung GH; Han YM; Lee SY; Jin GY; Lee JM
    AJR Am J Roentgenol; 2006 May; 186(5 Suppl):S261-8. PubMed ID: 16632686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Microwave and Radiofrequency Ablation for the Treatment of Small- and Medium-Sized Hepatocellular Carcinomas in a Prospective Randomized Trial.
    Vogl TJ; Martin SS; Gruber-Rouh T; Booz C; Koch V; Nour-Eldin NA; Hussainy Said MN
    Rofo; 2024 May; 196(5):482-490. PubMed ID: 38065541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microwave ablation is as effective as radiofrequency ablation for very-early-stage hepatocellular carcinoma.
    Xu Y; Shen Q; Wang N; Wu PP; Huang B; Kuang M; Qian GJ
    Chin J Cancer; 2017 Jan; 36(1):14. PubMed ID: 28103953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thermal ablation therapy for hepatocellular carcinoma: comparison between radiofrequency ablation and percutaneous microwave coagulation therapy.
    Ohmoto K; Yoshioka N; Tomiyama Y; Shibata N; Kawase T; Yoshida K; Kuboki M; Yamamoto S
    Hepatogastroenterology; 2006; 53(71):651-4. PubMed ID: 17086861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complications of microwave ablation for liver tumors: results of a multicenter study.
    Livraghi T; Meloni F; Solbiati L; Zanus G;
    Cardiovasc Intervent Radiol; 2012 Aug; 35(4):868-74. PubMed ID: 21833809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiofrequency ablation for the treatment of hepatocellular carcinoma with decompensated cirrhosis.
    Wakuta A; Nouso K; Kariyama K; Nishimura M; Kishida M; Wada N; Mizushima T; Higashi T; Tanimoto M
    Oncology; 2011; 81(1):39-44. PubMed ID: 21912196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
    Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiofrequency ablation for unresectable tumors of the liver.
    Howard JH; Tzeng CW; Smith JK; Eckhoff DE; Bynon JS; Wang T; Arnoletti JP; Heslin MJ
    Am Surg; 2008 Jul; 74(7):594-600; discussion 600-1. PubMed ID: 18646476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis.
    An C; Li WZ; Huang ZM; Yu XL; Han YZ; Liu FY; Wu SS; Yu J; Liang P; Huang J
    Eur Radiol; 2021 Jul; 31(7):4764-4773. PubMed ID: 33399908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.